ROME THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Jun 2024)
What this means for you
This application is over — abandoned 10 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88904215
- Mark type
- Stylized text
- Filed
- 06 May 2020
- Published for opposition
- 09 Mar 2021
- Abandoned
- 10 Jun 2024
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases; veterinary preparations for the treatment of oncology, autoimmune, neurodegenerative, and other related diseases
Owner
- ROME Therapeutics, Inc., Boston, MA, US
- Rome Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Jun 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Jan 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 03 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2023 — SOU EXTENSION 5 GRANTED
- 27 Oct 2023 — SOU EXTENSION 5 FILED
- 02 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 02 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2023 — SOU EXTENSION 4 GRANTED
- 28 Apr 2023 — SOU EXTENSION 4 FILED
- 28 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2022 — SOU EXTENSION 3 GRANTED